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 SUMMARY 
The colony stimulating factor-1 receptor (CSF-1R) is a tyrosine kinase receptor expressed in 
mammary tumors of canines and breast carcinomas of humans. The expression of this receptor 
has been associated with increased invasion and migration in vitro. In breast cancer patients,  
expression of CSF-1R in the tumor tissue is associated with increased levels of lymph node 
metastasis. Epithelial cancer cells can secrete the ligand, colony stimulating factor-1(CSF-1). 
CSF-1 may cause autocrine stimulation of the receptor and attract and educate macrophages 
towards a tumor associated macrophage (TAM) phenotype. The CSF-1R is also important in 
the regulation of macrophages in organogenesis including mammary development. In this 
study, the expression of CSF-1R in CMT-U229 avl 2 cell line was examined using flow 
cytometry and immunohistochemistry. During flow cytometry the cells were sorted in two 
groups of CSF-1R positive cells and CSF-1R negative cells. The migration and invasion of the 
CSF-1R positive and CSF-1R negative 2 was evaluated using a wound healing assay and 
Matrigel invasion assay. The CMT-U229 avl 2 cells expressed CSF-1R in 93 % of the cells 
according to the result of the immunohistochemistry and in 21.4 % of the cells according to the 
result of the flow cytometry. The CSF-1R positive cells showed a slight increase in migration 
rate and a larger increase in invasion compared to the CSF-1R negative cells. In conclusion the 
CSF-1R was expressed in the CMT-U229 avl 2 cell line and this expression could be associated 
with invasiveness in the CMT-U229 avl 2 cell line.   
 
 
SAMMANFATTNING 
Colony stimulating factor-1 receptor (CSF-1R) är en tyrosinkinasreceptor som uttrycks i 
juvertumörer hos hundar och bröstcarcinom hos människor. Uttryck av receptorn har kopplats 
till ökad invasivitet och migration in vitro. Hos bröstcancerpatienter är uttryck av CSF-1R i 
tumörvävnaden kopplat till ökade nivåer av metastasering till lymfknuta. Epitelial cancerceller 
kan även utsöndra liganden, colony stimulating factor (CSF-1). CSF-1 kan stimulera CSF-1R 
autokrint och attrahera makrofager samt förändra makrofager till en mer anti-inflammatorisk 
fenotyp. CSF-1R är även viktig för reglering av makrofager i organogenesen vilket inkluderar 
juverutveckling. I denna studie användes flödescytometri och immunohistokemi för att 
undersöka uttrycket av CSF-1R i cellinjen CMT-U229 avl 2.  Cellerna sorterades även i en 
grupp av CSF-1R positiva och en grupp av CSF-1R negativa celler. Migration och invasivitet 
utvärderades hos de CSF-1R positiva och CSF-1R negativa genom en så kallad wound healing 
assay och Matrigel invasion assay. 93 % av cellerna uttryckte CSF-1R vid immunohistokemi 
och 21.4 % av cellerna uttryckte receptorn vid flödescytometri. CSF-1R positiva celler visade 
en något större förmåga att migrera och en större ökning i förmågan till invasivitet jämfört med 
de CSF-1R negativa cellerna. Sammanfattat uttrycks receptorn CSF-1R av cellinje CMT-U229 
avl 2 och detta uttryck kan vara kopplat till ökad invasivitet.   
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LIST OF ABBREVIATIONS 
BSA Bovine serum albumin 
CSF-1R Colony stimulating factor 1 receptor 
CSF-1 Colony stimulating factor 1 
CCL2 C-C motif chemokine ligand 2 
CCL 8 C-C motif chemokine ligand 8 
𝐶𝑠𝑓1𝑟−/𝐶𝑠𝑓1𝑟− mice Homozygous disruption of the Csf-1r gene in mice 
𝐶𝑠𝑓1𝑜𝑝/𝐶𝑠𝑓1𝑜𝑝mice Osteoporotic CSF-1-nullizygous mice. 
DAB 3,3’-Diaminobenzidine 
DMEM Dulbecco’s  modified eagle medium 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EGFR Epidermal growth factor receptor 
EMT Epithelial mesenchymal transition 
ER Estrogen receptor 
Erk/MAPK Extracellular signal regulated kinases/Mitogen-activated protein kinases 
Ets E twenty-six 
FBS Fetal bovine serum 
G-CSF Granulocyte colony stimulating factor 
GM-CSF Granulocyte macrophage colony stimulating factor 
GRB2 Growth factor receptor-bound protein 2 
HBSS Hanks balanced salt solution 
HER2 Human epidermal growth factor receptor 2 
IHC Immunohistochemistry 
KI Kinase insert 
LPS Lipopolysaccharide 
PE Phycoerythrin 
PBS Phosphate buffer 
PG Progesterone receptor 
PtdIns 3/PI3K Phosphatadylinositol-4,5 biphosphate 3/Phosphoinositide 3-kinase 
PTK Protein tyrosine kinase 
PyMT Polyoma middle T oncoprotein 
TAM Tumor associated macrophage 
TGF- Transforming growth factor  
Tyr Tyrosine 
uPA Urokinase plasminogen activator 
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INTRODUCTION 
Expression and function of the colony stimulating factor receptor (CSF-1R) has been studied 
in human and canine mammary tumor cell lines and murine models. Canine mammary tumors 
previously studied had a high expression of CSF-1R and this expression has been associated 
with increased proliferation and metastasis. Learning more about the CSF-1R receptor and its 
role in mammary cancer pathogenesis of canines could improve treatment and diagnosis of 
canine cancer patients. In this study the CMT-U229 avl 2 cell line was analyzed for expression 
of CSF-1R and association between CSF-1R, migration and invasion in vitro. This has 
previously not been studied in the CMT-U229 avl 2 cell line and the aim of the study was to 
learn more about the role of CSF-1R in this tumor cell line. 
 
 
LITERATURE REVIEW 
Molecular structure of the receptor 
The colony stimulating factor receptor (CSF-1R) is a tyrosine kinase receptor with 
demonstrated ligand dependent protein tyrosine kinase (PTK) activity. There are six known 
tyrosine residues (Tyr) on the human CSF-1R receptor that become phosphorylated: Tyr 571, 
Tyr 561, Tyr 809, Tyr 723, Tyr 708 and Tyr 699 (Shurtleff et al., 1990; Roussel, 1997). These 
tyrosine domains of the CSF-1R receptor have been examined in murine fibroblasts with human 
CSF-1R transfected. Tyr 561 seems to be the primary binding site of the src family kinases. Tyr 
also 561 seems to be important for signal transduction in fibroblasts and is probably involved 
in changes of morphology and growth rate (Roche et al., 1995). Tyr809 likely stimulates 
mitogenity by signaling to myc and cyclin D. Tyr 809 may also induce activation of src, Ras, 
Erk 1 and Erk 2 (Roussel, 1997). Tyrosine residues 699, 708 and 723 are part of the kinase 
insert domain (KI) (Shurtleff et al., 1990). The KI stimulates PtdIns 3 kinase activity and 
mitogenesis but is not essential for either (Shurtleff et al., 1990). Studies of murine fibroblast 
CSF-1R show a connection of GRB2 to the tyrosine residue 697. Tyr697 corresponds to the 
human 699 residue (van der Geer and Hunter, 1993).  
 
 
The role of CSF-1R in physiology and reproduction 
General physiology 
The role of CSF-1R in the body has been studied using mice with targeted homozygous 
disruption of the Csf-1r gene ( 𝐶𝑠𝑓1𝑟−/𝐶𝑠𝑓1𝑟− )and CSF-1 nullizygous mice (𝐶𝑠𝑓1𝑜𝑝/
𝐶𝑠𝑓1𝑜𝑝) . 𝐶𝑠𝑓1𝑟−/𝐶𝑠𝑓1𝑟−  mice and  𝐶𝑠𝑓1𝑜𝑝/𝐶𝑠𝑓1𝑜𝑝 mice showed overall similar 
phenotypical changes but several of the phentypical characteristics of the 𝐶𝑠𝑓1𝑟−/𝐶𝑠𝑓1𝑟− 
mice were more severe. The fact that these phenotypical characteristics were more severe 
indicated that CSF-1 independent activation could have a subtle effect on CSF-1R. Both the  
𝐶𝑠𝑓1𝑟−/𝐶𝑠𝑓1𝑟−  mice and  𝑐𝑠𝑓1𝑜𝑝/𝑐𝑠𝑓1𝑜𝑝 mice were severely osteoporotic and lacked 
osteoclastic development at the metaphysis resulting in increased bone density of the 
metaphysis and shortened long bones. The growth rate and survival was lower. Before 8 months 
of age they showed decreased volume of femoral bone marrow and femoral bone marrow 
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cellularity. Production of blood monocytes and lymphocytes was decreased but production of 
granulocytes was increased. Levels of mononuclear phagocytes in liver, kidney, skin and 
synovial membranes were decreased. CSF-1R also affected normal reproduction, in that 
diestrus of females increased. All of these phenotypical changes indicated CSF-1R is important 
for development and functions of many organs and tissues of the body (Dai et al., 2002). Some 
macrophages expressing CSF-1R require CSF-1 and these macrophages seem to be important 
in tissue remodeling and organogenesis. (Cecchini et al., 1994) Levels of mononuclear 
phagocytes was decreased in several tissues like liver tissue, kidney tissue, skin and synovial 
in mice with homozygous disruption of CSF-1R (Dai et al., 2002).  
 
Mammary gland physiology 
The phenotype of the mammary glands of pregnant mice with homozygous disruption of CSF-
1R changes. The change of the mammary gland phenotype was likely caused by failure of 
branching morphogenesis of the ductal epithelium (Dai et al., 2002). Transgenic overexpression 
of CSF-1 and/or CSF-1R in the mammary gland of murine breast cancer model Polyoma middle 
T oncoprotein (PyMT) mice was on the other hand associated with increased ductal branching 
and proliferation of the mammary epithelium (Kirma et al., 2004). In the human breast tissue, 
CSF-1R and CSF-1 have been observed in epithelial cells that line lactating ducts and alveoli 
but CSF-1R has not been found in non-lactating epithelium (Sapi et al., 1998a). Lactogenic 
hormones like insulin and prolactin can increase the expression of CSF-1 but not CSF-1R in 
vitro. Glucocorticoids can increase the CSF-1R expression in vitro but has no effect on CSF-1 
expression (Kacinski, 1997). 
 
 
Hormonal regulation of CSF-1R and CSF-1 
Lactogenic hormones like insulin and prolactin can increase the expression of CSF-1 but not 
CSF-1R in vitro. Glucocorticoids can increase the CSF-1R expression in vitro but has no effect 
on CSF-1 expression (Kacinski, 1997). 
 
 
Localization of the receptor 
Expression of CSF-1R has been observed on both the cell surface and in the nucleus. In some 
breast carcinomas, CSF-1R can also localize within the nucleus associating with chromatin of 
carcinoma cells. The level of CSF-1R measured in western blot may vary depending on the 
type of buffer used, in some studies a buffer which mainly extracts plasma membrane proteins 
has been used (Barbetti et al., 2014). A study of 40 human invasive breast cancer tissue samples 
(luminal A and B, human epidermal growth factor receptor 2 (HER2)+/- triple negative) 
expressing CSF-1R showed that 9 samples expressed CSF-1R in both nucleus and cytosol, three 
expressed CSF-1R in the nucleus only and 28 expressed CSF-1R in only the cytoplasm (Barbetti 
et al., 2014).  
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CSF-1R found in mammary tumors and breast cancer 
Spontaneous mammary tumors in the murine mammary cancer model Polyoma middle T 
oncoprotein (PyMT) mice do not express CSF-1R, only the tumor associated macrophages 
express the receptor (Strachan et al., 2013). Presence of CSF-1R protein and mRNA expression 
of CSF-1R has been studied in various human mammary tumor cell lines. Many breast cancer 
cell lines in humans show some degree of CSF-1R surface protein, CSF-1 expression and CSF-
1R mRNA expression respectively (Morandi et al., 2011; Kacinski et al., 1991). In a study 
where flow cytometry was used to study the presence of CSF-1R in 15 different breast cancer 
cell lines (luminal and basal carcinomas, 5 of them Human epidermal growth factor 2 (HER2)+) 
from humans, 14 expressed appreciable levels of CSF-1R. Two immortal breast epithelial cell 
lines (MCF-10A and MCF-12A) were analyzed in the same study, these cell lines had extremely 
low levels of CSF-1R (<4 %) protein but showed relatively high levels of CSF-1R mRNA 
expression. The percentage of cells positive for the CSF-1R protein in each cell line varied from 
4 % - 25 %. (Morandi et al., 2011). The low levels of CSF-1R surface proteins may however 
not be enough to stimulate mitogenic response to CSF-1 (Wrobel et al., 2004). Presence of 
CSF-1R in carcinomas has also been analyzed immunohistochemically of slides from tissue 
samples, many of the breast carcinomas analyzed show presence of CSF-1R (Barbetti et al., 
2014; Kacinski et al., 1991). In a study of 581 breast cancer tissue samples with varying status 
of HER2, estrogen receptor (ER) and progesterone receptor (PR), 500 had some level of CSF-
1R staining (Kluger et al., 2004). Secretion of CSF-1 also seems to be common in breast 
carcinomas. In the previously mentioned study of 14 breast carcinoma cell lines (Luminal, basal 
A and B) and two immortal epithelial cell lines using ELISA and western blot, all showed some 
level of CSF-1 secretion (Morandi et al., 2011). In one immunohistochemical study of slides 
from breast carcinoma tissue samples the majority of cells were negative for CSF-1 (Kacinski 
et al., 1991). From another study, 34 of 37 examined infiltrating ductal carcinomas and 12 of 
13 lobular carcinomas were positive for CSF-1 expression. However, only 5/14 of preinvasive 
carcinomas were positive for CSF-1 expression (Tang et al., 1992). Level of CSF-1R transcripts 
in epithelial cells correlated with histological grade and clinical stage in carcinomas (Kacinski, 
1997)  Król et al. published a study of CSF-1R expression in 5 canine mammary tumor cell 
lines (adenocarcinoma, anaplastic cancer, simple carcinoma and spindle cell mammary tumor). 
When flow cytometry was used all of these cell lines expressed CSF-1R in a higher degree than 
previously reported in human cell lines The percentage of cells expressing CSF-1R varied from 
58.7 % to 88.7 % (Król et al., 2013).  
 
 
The role of CSF-1R in cancer 
The exact role CSF-1R and CSF-1 seems to vary with different cell lines, species or if evaluated 
through in vivo or in vitro methods. CSF-1R has been demonstrated to increase tumor 
progression and invasion in two different ways (Patsialou et al., 2009): (1)Autocrine 
stimulation in which the tumor cells express CSF-1R and excrete CSF-1. (2) Tumor cells secrete 
CSF-1, CSF-1 binds to the CSF-1R of macrophages or monocytes which attracts macrophages 
to the tumor and influences the phenotype of the macrophages. The macrophages then increase 
the invasiveness of the tumor cells, this may involve secretion of CSF-1 by the macrophages. 
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CSF-1 signaling to macrophages 
Epithelial tumor cells can secrete CSF-1 which attracts tumor associated macrophages (TAMs), 
Epidermal growth factor (EGF) was secreted by the macrophage binding to EGFR of the tumor 
cells. (Goswami et al., 2005; Wyckoff et al., 2004; Patsialou et al., 2009). This paracrine 
interaction with macrophages has been observed in both murine mammary carcinoma cells 
(PyMT) and human breast carcinoma cells. CSF-1 signaling increases motility of macrophages 
in vivo, which was regulated through the 721 phosphorylation site in association with PI3K 
(Sampaio et al., 2011). Apart from secreting EGF, TAMs can also affect cancer cells (including 
carcinomas, spindle cell tumors, anaplastic cancer) in several different ways like upregulation 
of genes involving inflammation, apoptosis, increased angiogenesis, increased expression of C-
C motif chemokine ligand 2 (CCL2) and increased expression of CSF-1R. (Rybicka et al., 
2016) (Król et al., 2013). An in vitro study of 5 canine mammary tumor cell lines (including 
CMT-U27) co-cultured with macrophages showed an increased expression of CSF-1R and 
higher migration rate of the co-cultured tumor cells in all cell lines (Król et al., 2013; Król et 
al., 2012). TAMs found in tumor tissue has been correlated to metastasis in canine mammary 
carcinomas (Król et al., 2011). When the same 5 cell lines were cultured without macrophages 
in vitro but supplemented with exogenous CSF-1 the expression of CSF-1R increased and the 
increased expression of CSF-1R was associated with increased migration rate in the wound 
healing assay (Król et al., 2013). When the CMT-U27 cell line was co-cultured with 
macrophages in another study it affected carcinoma cells in several different ways like 
upregulation of genes involving inflammation, apoptosis, increased angiogenesis, increased 
expression of CCL2 . The effect on CSF-1R or CSF-1 expression was not mentioned in this 
study (Rybicka et al., 2016).  
 
The ratio of CSF-1/Granulocyte macrophage colony stimulating factor (GM-CSF) affected 
genes in the development from monocytes to macrophages (Brochériou et al., 2011). CSF-1 
increased the expression of CCL2 and C-C motif chemokine ligand 8 (CCL8) and increased the 
secretion of CCL2, CCL2 is important for macrophage recruitment and (Lipopolysaccharide) 
LPS-induced activation of macrophages. (Sierra-Filardi et al., 2014; Beirão et al., 2015).  
 
CSF-1R inhibition could delay tumor growth in mammary carcinomas in PyMT mice and 
cervical carcinomas in mice, by decreasing the recruitment of TAMs and enhancing infiltration 
of CD8+ T-cells (Strachan et al., 2013). Overexpression of CSF-1 in the mammary gland may 
on the other hand increase infiltration of tissue macrophages and cause preneoplastic changes 
in mammary tissue (Kirma et al., 2004). PyMT mice lacking CSF-1 showed delayed lung 
metastases, delayed progression to a more aggressive carcinoma stage and decreased levels of 
infiltrating macrophages. PyMT mice expressing CSF-1 do on the other hand have increased 
levels of TAMs right before this progression and focal infiltrations of leukocytes were often 
seen (Lin et al., 2001).  
 
In another study on lung cancer, CSF-1R inhibition did however not affect pulmonary 
metastasis (Strachan et al., 2013; Patsialou et al., 2009). Anti CSF-1R treatment did also 
increase metastasis to the lungs and tumor draining lymph nodes in the murine 4T1 stage IV 
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breast cancer model (Hollmén et al., 2016). This breast cancer model is known to excrete high 
levels of Granulocyte colony stimulating factor (G-CSF) (Waight et al., 2011). When CSF-1R 
was inhibited in this model, G-CSF mediated a type of anti-inflammatory TAMs. G-CSF can 
also recruit anti-inflammatory monocytes to the tumor. Anti-CSF-1R treatment can lead to a 
decreased number of subcapsular sinus CD169+macrophages and, these macrophages are 
important for induction of anti-tumor immunity (Hollmén et al., 2016) (Asano et al., 2011).   
 
 
Autocrine CSF-1 signaling 
Human breast carcinoma cells may be less dependent on macrophages compared to carcinoma 
cells in murine breast cancer model PyMT (Wyckoff et al., 2004; Patsialou et al., 2009). The 
human MDA-MB-231(triple negative basal like) cell line was dependent on both paracrine 
signaling involving EGF and autocrine signaling. The autocrine regulation was amplified in 
vivo through a tumor environment induced upregulation of CSF-1R expression (Patsialou et al., 
2009). Transforming growth factor β (TGFβ) seems to be responsible for this upregulation of 
CSF-1R. Another in vitro wound healing assay of the human MCF-10A epithelial cell line 
(infected by retrovirus to express more CSF-1R) showed increased migration in cells co-
expressing CSF-1R and CSF-1 compared to CSF-1R expressing cells treated with CSF-1 
(Wrobel et al., 2004). The coexpression of CSF-1R and CSF-1 of MCF-10A cells also induced 
hyperproliferation and a profound disruption of junctional integrity of acinar structures. 
Overexpression of either CSF-1R or CSF-1 was associated with preneoplastic changes in PyMT 
mice that could lead to tumor formation. (Kirma et al., 2004).  
 
 
MATERIALS AND METHODS 
Cell lines 
CMT-U229 avl2 is a cell line established from an atypical canine mammary complex adenoma 
(Hellmén, 1992). 
 
 
Flow cytometry 
The cells were harvested by trypsinization. The cell concentration was calculated using a Bürker 
chamber and 1×105 cells were added to each test tube. The cells were centrifuged 5 minutes at 
1000 rpm. The supernate was removed and the primary antibody was added in 100 µl Hanks 
balanced salt solution (HBSS) with 2 % fetal bovine serum (FBS). The primary antibody used 
was anti-mouse CD-115 for CSF-1R (concentration 0.2 µg/µl eBioscience Catalog No:12-1152 
(Thermo Fisher Scientific, Waltham, MA, USA) and rat IgG2a-PE (0,2 µg/µl eBioscience, BD 
Pharmingen Catalog: 553930 (Stockholm, Sweden) for the control. After incubation for 15 
minutes on ice the solution was suspended in HBSS with 2 % FBS to a final volume of 250 µl. 
The cells were kept on ice until the flow cytometry analysis. The CSF-1R expression of the 
CMT-U27 cell line, which has previously been shown to expressed CSF-1R to a high degree, 
was also analyzed as a positive control. The following samples were analyzed. 
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 CMT-U229 avl CSF-1R-PE  
 CMT-U229 avl Rat IgG2a-PE (isotype control) 
 CMT-U229 avl unstained (control) 
 CMT-U27 CSF-1R-PE 
 CMT U27 Rat IgG2a-PE (isotype control) 
  CMT U27 unstained (control) 
 
The cells were analyzed using Bio-rad S3e cell sorter and FACSDiva 8.0.1 software (BD 
Biosciences). Gating was first made based on morphological criteria, then the CSF-1R positive 
cells were gated showing the amount of CSF-1R-positive cells in the cytoplasm. Cut off Value 
for the CSF-1R positive and CSF-1R negative cells was decided based on the level of 
Phycoerythrin (PE)-fluorescence. 
 
 
Immunohistochemistry 
All slides were deparaffinized in xylene and decreasing alcohol concentration 1 % H2O2 
suspended in absolute alcohol. Then the slides were boiled in a Decloaking chamber (Biocare 
medical) with 500 ml of distilled water and unmasking solution (Vector 1:100) for 8 minutes. 
After boiling, the slides were left in the chamber for 60 minutes with the lid on to allow the 
pressure and temperature to decrease. Then the slides were washed with distilled water three 
times and then Tris buffer (0,05 M Tris-HCl pH 7,6) three times. All slides were incubated with 
normal goat serum for 60 minutes (1:50) to block non-specific-bindings. The primary antibody 
used for CSF-1R was a rabbit polyclonal (ABIN683788, antibodies online) diluted at 1:100 and 
1:500. The slides were incubated with the primary antibody at +4ºC overnight. After incubation 
with the primary antibody the slides were washed with Tris buffer three times 5 minutes. 
Biotinylated anti-rabbit (1:200) was used as the secondary antibody, and the slides were 
incubated for 30 minutes, after this the slides were again washed in Tris three times. ABC-Elite 
was prepared suspending 20 µl of reagent A and 20 µl of reagent B in 1 ml of the Tris buffer 
and left for 30 minutes before use. The slides were washed again with Tris buffer and thereafter 
incubated with ABC-elite solution for 45 minutes. After ABC-Elite the slides were washed with 
Tris buffer as above. 3,3’-Diaminobenzidine (DAB) was used as substrate and consisted of a 
solution of 2,5 ml distilled water, 2 drops of buffer, 2 drops of DAB and 1 drop of H2O2 (Vector 
Burlingame, CA, USA). After DAB the slides were washed with distilled water three times. 
Mayer’s hematoxylin was used to counterstain the nuclei. The slides were then washed in tap 
water and dehydrated two times in 95 % and absolute alcohol respectively. After this the slides 
were cleared in xylene and mounted in Pertex (Histolab Sweden). More than 100 cells from 
each slide were photographed using a Nikon microscope. ImageJ and the IHC toolbox plugin 
for ImageJ were used to process light micrographs to find DAB-staining. The level of staining 
was determined based on the processed light micrographs and the original light micrographs. 
Two slides of CSF-1R positive cells (1:100 and 1:500) and one slide of CSF-1R negative cells 
from each cell line were used. Canine lymph node tissue and the cell line CMT-U27 were used 
as positive controls. This experiment was conducted one time. 
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Wound healing assay 
The sorted CSF-1R positive and CSF-1R negative cells were harvested by trypsinization. The 
concentration of cells was decided by cell counting using a Bürker chamber. Approximately 
4x104 cells were suspended in 20 ml Dulbecco’s modified eagle medium (DMEM) cell culture 
medium supplemented with 5 % Fetal bovine serum (FBS), one batch of CSF-1R positive cells 
and one batch of CSF-1R negative cells. The cells were seeded from the test tubes into 6 
different 60 mm dishes, three dishes of CSF-1R positive cells and three dishes of CSF-1R 
negative cells respectively. The dishes were then placed in a cell culture incubator at 37oC and 
5 % CO2 until the cells had grown into a confluent layer. The dishes of CSF-1R positive cells 
had grown into a confluent layer after 8 days and the CSF-1R negative cells took 9 days to grow 
into a confluent layer of cells. When the cells had grown into a confluent layer a scratch was 
made by drawing a line through the cell layer across the plate using a pipet tip. The scratch was 
made after removing the cell culture medium and adding three ml of phosphate buffer (PBS) to 
the plate. Markings were made at the bottom of the plate at different sites of the scratch to make 
sure that the same view was photographed at every time point. The cells were then washed two 
more times with PBS to smooth out the edges and remove debris from the medium. Five ml of 
fresh DMEM cell culture medium with 5 % FBS was added to the plates. The scratch was 
photographed using a Lumenera Infinity 1 camera at the marked sites after the scratch was 
made. The sites were then photographed three more times at intervals of two hours. After 6 
hours, the gap was closed at some sites. The cells were kept in a cell culture incubator at 37 oC 
when they were not being photographed. The average gap closing speed per hour was calculated 
in every light micrograph using ImageJ and Microsoft Excel.  
 
 
Invasion assay 
The Corning BioCoat Growth Factor Reduced Matrigel Invasion Chamber, 24-well was used 
for the invasion assay and Corning BioCoat Control Inserts, 24-well was used for control 
(Corning, Bedford, MA, USA). The cells were grown in serum-free DMEM during 24 hours 
before the experiment started. The membrane of the inserts in the Matrigel invasion chamber 
was rehydrated by filling every insert with 0.5 ml serum-free DMEM and then placing the 
inserts in an incubator at 37 oC. The sorted CSF-1R positive and the CSF-1R negative cells 
were grown in different dishes and at about 80 % confluency the cells were harvested by 
trypsinization and suspended in two test tubes, respectively. The concentration of the harvested 
cell in each cell suspension was calculated using a Bürker chamber. After 2 hours of rehydration 
the Matrigel invasion chamber was taken out of the incubator. The six lateral wells to the left 
were filled with 0.75 ml DMEM with 5 % fetal bovine serum (FBS) and the six lateral wells to 
the right were filled with serum-free DMEM. The inserts were filled with the cell suspension, 
0.5 ml DMEM and 0.1 % BSA with 2.5x104 cells/well. Six of the inserts were filled with CSF-
1R negative cells and six of the inserts were filled with CSF-1R positive cells. Of the six inserts 
containing CSF-1R positive cells, three were placed in wells with serum free DMEM and three 
were placed in wells with DMEM and 5 % FBS. The same thing was done to the control inserts. 
Both the Matrigel invasion chamber and the control plate were incubated in 37 C and 5 % CO2. 
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After 24 hours the Matrigel invasion chamber plate as well as the control plate were taken out 
of the incubator and the cells were fixated. One by one, the inserts were scrubbed with a cotton 
swab to remove free cells and then placed in formalin for fixation during 6 minutes. The 
membranes were then stained in hematoxylin for 6 minutes each and stained with eosin for 20 
seconds. After being put in eosin each insert was washed with distilled water and then placed 
with the bottom up to dry for one hour. The same thing was done with the controls. 
 
After drying off the membrane was cut out from the inserts using a scalpel and the membranes 
were assembled with the bottom up on a glass slide. The number of cells were counted manually 
in the center of every membrane using the 40 x objective. The invasion percentage was 
calculated according to the manufacturers manual. This means that the average number of 
invading cells counted in the membrane of the Matrigel coated inserts were divided with the 
corresponding membrane of the uncoated control inserts. For example, the membrane of the 
coated insert with CSF-1R positive cells incubated with FBS in the well were divided with the 
number of cells in the membrane of the uncoated control insert with FBS in the well. This way, 
the ability of the cells to migrate could be separated from the ability to invade through the 
Matrigel. The invasion percentage is the percentage of migrating cells which also had the ability 
to invade through the Matrigel coated membrane. 
 
 
Statistical analysis 
Statistical analysis of the wound healing assay was conducted using the student’s t test in 
Microsoft Excel analyzing the average wound healing rate per hour. Average wound healing 
rate per hour was calculated based on the graphs of the wound healing made in Microsoft Excel, 
mean wound healing rate expressed in mean +/- S.D. P-value <0.05 was regarded as significant 
and p-value <0.001 was regarded as highly significant. Because the invasion assay, flow 
cytometry and immunohistochemistry was only conducted once as described in the results no 
statistical analysis was made of this data. 
 
RESULTS 
Flow cytometry 
Flow cytometry was used to determine the level of CSF-1R expression and to sort the CSF-1R 
positive from the CSF-1R negative cells. The expression of CSF-1R was 24.5 %. Zero percent 
of the cells were positive for the CSF-1R receptor using isotype control and unstained control 
cells indicating absence of non-specific background signals. CMT-U27 cells were also analyzed 
by flow cytometry as a positive control and, the expression of CSF-1R in this cell line was 37.0 
%. This experiment was conducted one time. (Figure 1). 
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Figure 1. Expression of CSF-1R in the canine mammary tumor cell line CMT-U229 avl 2 
unsorted cells passage 137. Histograms of (A)CSF-1R-PE-stained sample with 24.5 % CSF-
1R-positive cells, (B) Isotype control with 0 % CSF-1R positive cells, (C) Unstained control 
with 0 % CSF-1R positive cells. Bio-rad S3e cell sorter and BD FACSDiva 8.0.1 software (BD 
Bioscience) was used to analyze the expression. 
 
A 
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Immunohistochemistry 
The unsorted CMT-U229 avl 2 cells with the primary CSF-1R antibody diluted at 1:100 had 93 
% positive cells and 7 % negative cells. Thirtytwo percentage of the cells had a strong DAB-
staining. The macrophages of the positive control slides of canine lymph node were strongly 
positive with the CSF-1R antibody. CMT-U27 was used as a positive control and showed 
positive staining in 29 % of the cells. The cells from the cell lines were only counted as positive 
when the cytoplasm had a DAB staining. The negative control slide of the canine lymph node 
also had a brown coloring of the macrophages. This experiment was conducted one time (Figure 
2) 
 
 
Figure 2. Expression of CSF-1R in the canine mammary tumor cell lines CMT-U229 avl 2 
unsorted and positive control CMT-U27 using immunohistochemistry. Representative light 
micrographs were taken at 20 x magnification of: (A) Stained CMT-U229 avl 2 cells, 93 %  
showed a positive DAB-stain and  29 % of them showed a strong positive staining. (B) 
Unstained negative control of the CMT-U229 avl 2 cell line. No cells in the negative unstained 
control had any brown coloring. (C) Positive control cells from the CMT-U27 cell line and, 29 
% of the cells had a positive DAB-staining. (D) Unstained  CMT-U27, no cells had any brown 
coloring. DAB was used as a substrate and Mayer’s hematoxylin was used as a nuclear 
counterstain in all samples. 
A 
C D 
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Wound healing assay 
The average wound healing rate of the CSF-1R positive cells was 17.5 % higher than the 
average wound healing rate of the CSF-1R negative cells. Statistical analysis showed a P value 
of 0.000037 which makes the result highly significant. These results indicate that expression of 
CSF-1R is correlated with a higher migratory ability for the CMT-U229 avl 2 canine mammary 
cell line. The average wound healing rate of the CSF-1R positive and CSF-1R negative cells 
was very similar for the first two hours. After two hours had passed the wound healing of the 
CSF-1R positive cells started to increase compared to the CSF-1R negative cells making the 
total wound healing during the six hours higher for the CSF-1R positive cells. The wound 
healing of the CSF-1R negative cells increased to a similar rate as the CSF-1R positive cells 
after four hours. The wound healing assay was terminated after six hours because some wounds 
were almost completely closed making analysis of the wound area difficult. After six hours, on 
average 38 % of the wound had closed in the CSF-1R positive dishes and 32 % of the wound 
in the CSF-1R negative dishes. Since the scratch was made using a pipette tip it was not possible 
to make the width of the wound the same in every dish, the average size of the wound was 
however very similar in the CSF-1R positive and the CSF-1R negative cells (Figure 3 and 
Figure 4).  
 
 
 
 
 
 
 
 
  
 
Figure 3. Wound healing assay 
of the CMT-229 avl 2 cell line, 
comparing the migration rate of 
CSF-1R positive and CSF-1R 
negative cells. A wound was 
first made using a pipette tip, 
light micrographs were then 
taken at time intervals and the 
decreasing wound area was 
measured. The images show 
representative light micrograph 
of the (A) CSF-1R positive cells 
and (B) CSF-1R negative cells 
at time 0 hours (0 h), two hours 
(2 h), four hours (4 h) and six 
hours (6 h).  The wound healing 
rate of the CSF-1R positive cells 
were 17.5 % higher than the 
CSF-1R negative cells and the 
difference was statistically 
significant (P<0.000037). This 
indicates that the CSF-1R 
positive cells have an increased 
ability to migrate compared to 
the CSF-1R negative cells. 
 
B 
A 
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Figure 4. Graph of the 
average decreasing wound 
area (y) per hour (x) in the 
dishes with CSF-1R positive 
cells and the dishes with 
CSF-1R negative cells. The 
decrease in wound area per 
hour corresponds to the 
average migration rate. The 
average migration rate of 
the CSF-1R positive and 
CSF-1R negative cells were 
similar for the first two 
hours. Then the average 
migration rate of the CSF-
1R positive cells increased. 
After four hours the average 
migration rate of the CSF-
1R negative cells increased 
to the same migration rate 
as the CSF-1R positive cells. 
 
Invasion assay 
Differences between CSF-1R positive and CSF-1R negative cells when FBS was used 
as a chemoattractant 
The invasion percentage of the CSF-1R positive cells was much higher compared to the CSF-
1R negative cells (35.44 % compared to  4.77 %). The average number of cells counted were 
greater for the CSF-1R positive cells compared to the CSF-1R negative cells in both the 
Matrigel coated inserts and the control inserts. This indicates that while the migratory capacity 
of the CSF-1R positive cell was higher than the CSF-1R negative cells the difference in invasive 
capacity was even greater (Figure 5 and Table 1). 
 
Differences between Matrigel coated inserts and uncoated control inserts when FBS 
was used as a chemoattractant 
When the CSF-1R positive and CSF-1R negative cells were added together and divided with 
the control the invasion percentage was 23.6 %. The decreased level of cells in the Matrigel 
coated inserts indicates that the Matrigel coat works as a barrier inhibiting some cells to pass 
through the pores while other cells could invade through the Matrigel. The cells in the control 
inserts could move through the pores more easily because no Matrigel layer was there to stop 
them. The cells of the control inserts showed a different morphology with a more elongated 
shape than the cells from the Matrigel-coated membranes, this shape is similar to how the cells 
0
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look when they are attached to the bottom of a dish. The cells from Matrigel coated membranes 
had a rounder shape with protrusions pointing in different directions (Figure 5 and Table 1). 
 
 
           
 
 
           
 
 Figure 5. Representative light micrographs of the cells in the membranes of the inserts used in 
the invasion assay. The light micrographs were taken at 40 x magnification in the center of the 
membrane. CSF-1R positive cells from (A) Matrigel coated inserts and (B) uncoated control 
inserts and CSF-1R negative cells from (C) Matrigel coated inserts and (D) uncoated control 
inserts. Morphological differences were seen between the cells in the Matrigel coated inserts 
and uncoated control inserts. The cells of uncoated inserts had an elongated shape while the 
cells of the Matrigel coated inserts had a rounder shape. 
 
Differences between inserts in wells containing cell culture medium with FBS or wells 
containing cell culture medium without FBS 
FBS added to the well clearly increase the invasive behavior of the cells. On average only 0.67 
cells were found in the center field of the coated inserts and 0 cells were found in the center 
field of the control membranes. The invasive percentage of the cells could not be evaluated 
when serum-free medium was used in the wells because the average number of cells counted 
in the membrane was very low (0-2 cells), (Table 1). 
 
 
A B 
C D 
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Table 1. Table of the average number of cells found at the center of the membranes (CSF-1R 
positive/negative, Matrigel coated/uncoated control, FBS added/not added to the well). The 
number of cells was counted in the center of the membrane at 40 x magnification. The invasion 
percentage was calculated by dividing the average number of cells at the center of a Matrigel 
coated membrane with the average number of cells in the center of the corresponding uncoated 
control membrane. The invasion percentage of the CSF-1R positive cells was higher than the 
invasion percentage of the CSF-1R negative cells(35.44 % to 4.77 %). The number of cells in 
the inserts with no FBS added to the well was very low in both the inserts containing CSF-1R 
positive and inserts containing CSF-1R negative cells (not shown). 
 Matrigel insert Control insert % Invasion 
CSF-1R positive with 
FBS 
19.67 55.5 35.44  
CSF-1R positive 
without FBS 
0.67 0 - 
CSF-1R negative with 
FBS 
1.67 35 4.77 
CSF-1R negative 
without FBS 
0 0 - 
 
 
Limitations of the first conduction of the experiment 
This experiment was conducted two times but only the second time is described above. The 
first time the level of cells found in the membrane was very different in each individual group 
making it difficult to note a difference between the CSF-1R positive and CSF-1R negative. 
There were also a lot of cells in some of the membranes, sometimes overlapping each other 
making cell counting difficult. In this first experiment control inserts were not used making 
calculation of invasion index impossible. There was a clear lack of cells in the membranes of 
inserts placed in wells without FBS in both the first and second experiment confirming this 
result. Cells were also found in the membrane of inserts containing both the CSF-1R positive 
and CSF-1R negative cells confirming that both the CSF-1R positive and CSF-1R negative 
cells had the ability to invade the Matrigel. 
 
 
DISCUSSION 
Expression of CSF-1R in the CMT-U229 avl 2 cell line 
This study confirms that expression of CSF-1R is common in canine mammary tumor cell lines. 
The expression seems to be more common in canine mammary tumor cell lines compared to 
human breast cancer cell lines and more cells in each cell line express the receptor (Morandi et 
al., 2011; Król et al., 2013) In a previous study of 14 human breast cancer cell lines no cell 
lines expressed CSF-1R in more than 25 % of the cells. (Morandi et al., 2011). Canine 
mammary tumor cell lines studied by Król et al. on the other hand expressed CSF-1R in over 
50 % of the cells in each cell line (Król et al., 2013). So why is the expression of CSF-1R so 
much higher in canine mammary cancer? The CSF-1R receptor could play a more important 
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role in tumor development of canines compared to humans. The increased expression of CSF-
1R in canine mammary tumor cell lines does not in itself indicate that CSF-1Rs play are more 
important role in cancer pathogenis in female dogs. The role of CSF-1R expression in the tumor 
cell is also affected by for example the levels of CSF-1 binding to the receptor, the signaling 
pathways activated by the receptor or overactivity of the receptor. To my knowledge the 
expression of CSF-1R has not been studied in normal mammary tissue of canines. Thus, it 
would be interesting to study the expression of CSF-1R in normal canine mammary tissue and 
compare it to the expression of CSF-1R in canine mammary tumor tissue. The receptor can be 
expressed in normal non-cancerous breast epithelium of humans during lactation (Sapi et al., 
1998a). Insulin and prolactin did not influence the expression of CSF-1R in human mammary 
epithelium in vitro but could increase the expression of CSF-1, especially when insulin and 
prolactin were added together (Kacinski, 1997). This increased CSF-1 expression could 
possibly attract macrophages, increase CSF-1R expression and bind to CSF-1R in vivo 
explaining the increased CSF-1R expression during lactation. The canine mammary gland goes 
through changes similar to lactation during diestrus including ductal arborization, 
lobuloalveolar differentiation and secretory capacity (Santos et al., 2010). These differences in 
mammary structure means that it cannot be assumed that the receptor would only be expressed 
during lactation or in cancerous tissues of canines. The studies previously described about the 
role of CSF-1R in mammary gland development and cancer pathogenesis of mice does not 
describe any expression of CSF-1R in the murine mammary epithelium. This makes it difficult 
to know the role of CSF-1R in the canine mammary gland based on studies of CSF-1R and its 
role in the mammary gland in murine models.  
 
 
The role of CSF-1R in CMT-U229 avl 2 
Since the CMT-U229 avl2 CSF-1R positive cells migrated and invaded the membrane to a 
larger degree it is likely that CSF-1R expression is associated with increased migration and 
invasion. However the fact that the CSF-1R negative cells also migrated and invaded indicates 
that some other cell signaling pathways also drive the migration and invasion of cells in this 
cell line independent of the CSF-1R expression. It is also unclear if ligand binding by CSF-1 
(possibly from fetal bovine serum) or autocrine stimulation is what increased invasion of the 
CSF-1R positive cells. While the group of CSF-1R positive cells did have better migratory and 
invasive abilities, the invasion was also not necessarily induced by stimulation of CSF-1R. 
Instead expression of CSF-1R could correlate with a population of CMT-U229 avl 2 cells which 
happens to be of a migratory and invasive phenotype. Macrophages can change the phenotype 
and gene expression of canine tumor cells in many ways making them more invasive (Król et 
al., 2012; Król et al., 2014). This means that while the increased CSF-1R expression is 
indicative of exposure to CSF-1 secreted by TAMs or the tumor cells, some other factor 
involving TAMs could also increase invasiveness of the CSF-1R positive cells.  
 
Incubation of canine mammary tumor cells with TAMs lead to a switch from canonical to a 
non-canonical Wnt pathway. (Król et al., 2014). This lead to changes in the morphology of 
neoplastic cells with formation of branches. Phosphorylation of fascin and formation of 
complexes with protein kinase C was caused by activation of non-canonical Wnt-signaling and 
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fascine is essential for the formation of philopodia which is associated with increased net 
protrusion (Mejillano et al., 2004). Since macrophages increase the expression of CSF-1R and 
cause this switch to the non-canonical Wnt-signaling the increased motility of the CSF-1R cells 
could also be explained by these cytoskeletal changes. Macrophages secreted epithelial 
mesenchymal transition (EMT)-activators and the secretion was further induced by neoplastic 
cells (Król et al., 2014). Epithelial mesenchymal transition is a process in which epithelial cells 
lose epithelial characteristics and become more like mesenchymal cells. Conversion of breast 
epithelial cells to a mesenchymal phenotype has previously been shown to increase invasion, 
migration and create a claudin-low phenotype compared to epithelial cells (Asiedu et al., 2011). 
Co-culture of canine mammary tumor cells with TAMs can decrease expression of the epithelial 
marker cytokeratin and increase expression of mesenchymal marker vimentin (Król et al., 
2014). Vimentin has been known to be required in a human breast carcinoma cell line (MDA-
MB-231) for the function of a type of protrusions which are involved in invasion through the 
basement membrane (Schoumacher et al., 2010). However expression of CSF-1R and increased 
invasion have previously been proven to increase after exposure to CSF-1 without co-culturing 
with macrophages (Król et al., 2013). The only known ligands to the CSF-1R receptor is CSF-
1 and IL-34. Since homozygous depletion of the CSF-1R leads to a similar phenotype as the 
𝐶𝑠𝑓1𝑜𝑝/𝐶𝑠𝑓1𝑜𝑝mice it is likely that CSF-1 is the most important ligand for CSF-1R (Dai et 
al., 2002). The ability of IL-34 to induce migration and invasion has to my knowledge not been 
examined. 
 
 
Autocrine and exogenous CSF-1R signaling 
Transfection of CSF-1R to a mammary epithelial cell line which expresses large quantities of 
CSF-1 can increase invasion without adding exogenous CSF-1, exogenous CSF-1 might not 
increase invasion more in a mammary epithelial cell line with high CSF-1 expression (Sapi et 
al., 1996). Autocrine CSF-1R stimulation may have a larger effect on invasion compared to 
exogenous CSF-1 and this is regulated by TGF-β (Patsialou et al., 2015). CSF-1R expression 
is regulated by TGF-β specifically in claudin-low breast carcinoma cell lines and CSF-1R 
expression is higher in claudin low cell lines. Autocrine CSF-1R signaling leads to increased 
invasion in claudin low cell lines and also maintains a claudin-low state and attenuates 
expression of tight junctions. Proliferation of the claudin-low cell lines was on the other hand 
decreased by TGF-β stimulation. TGF -β was expressed in the membranes of the inserts used 
in this invasion assay and this could possibly increase the autocrine CSF-1R stimulation leading 
to increased invasion (Wrobel et al., 2004). Expression of CSF-1 has not been evaluated for the 
CMT-U229 avl 2 cell line, but since CSF-1 expression is common in breast cancer cell lines, 
autocrine CSF-1R stimulation or secretion of CSF-1 is a possibility (Morandi et al., 2011).  The 
level of claudin-expression in the CMT-U229 avl 2 cell line is however not known. It is also 
possible that the fetal bovine serum (FBS) contains some CSF-1, in addition to other growth 
factors, which could stimulate the receptors. Serum starvation can decrease the mean expression 
and phosphorylation of CSF-1R (Król et al., 2013). A study of collected bovine serum from 
fetuses age 152-278 days of gestational age at slaughterhouses show that the serum contained 
bovine CSF-1 and the level differentiates among individuals. This study did however not 
mention if bovine CSF-1 would have any effect on human or canine cells. (Yoshihara et al., 
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2003). No invasion or migration was seen in the inserts placed in FBS free medium in the 
invasion assay. This could be because the FBS-free medium lacked CSF-1 but other signal-
substances in the FBS could also have influenced the cells to migrate into the membrane. Fetal 
bovine serum may also contain TGF- among other growth factors (Zheng et al., 2006). Of 
course it is possible that the CSF-1R receptor in this cell line could be stimulated by a 
combination of autocrine as well as exogenous CSF-1. When CSF-1R expression in canine 
mammary carcinomas was analyzed CSF-1R was found in both macrophages and carcinoma 
cells and this total CSF-1R expression was related to the ability to metastasize (Król et al., 
2011; Gonçalves et al., 2016).  
 
 
CSF-1R and cell migration 
CSF-1R has previously been shown to disrupt cell adhesions by relocalization of E-cadherin 
from the membrane to intracellular vehicles in breast epithelium cells, this likely contributes to 
increased motility (Wrobel et al., 2004). This CSF-1R signaling pathway is dependent on Src. 
The CMT-U229 avl 2 cell line expresses E-cadherin and, CSF-1R could have the same effect 
on E-cadherin in this cell line and thereby increase motility and migration of the cells.  Usually 
a few cells would separate from the wound margin and move into the gap before the wound 
margins would start to move closer together. The disrupted adhesions might have made it easier 
for the individual cells of the CSF-1R positive group to migrate into the wound early. There is 
also the possibility that some of these cells seen on their own in the wound gap are single cells 
floating in the medium which attached to the bottom of the well in the middle of the gap. Free 
cells floating in the cell culture medium were sometimes observed in both the CSF-1R positive 
and CSF-1R negative group despite carefully and repeated washing the dish with PBS and 
changing cell culture medium right after the scratch was made. Ideally this experiment should 
have been conducted until the wound of both the CSF-1R positive cells and the CSF-1R 
negative cells had closed completely. Since the wound healing rate of the CSF-1R positive and 
CSF-1R negative cells was very similar for the last 2 hours it is possible that the wound healing 
rate would have continued to be similar in both cell lines until wound was completely closed, 
making the wound healing rate more similar if measured for a longer time.  
 
 
CSF-1R and cell invasion 
The increased invasion of the CSF-1R positive cells in this study is similar to the results of the 
invasion assay reported by Król et al. (2013). CSF-1 has also been shown to increase invasion 
in several human and murine cancer cell lines like  ovarian carcinoma, lung carcinoma and 
mammary carcinoma (Chambers et al., 1995; Filderman et al., 1992; Patsialou et al., 2009) 
Although it is established that CSF-1R can increase invasion in many cancer cell lines, adding 
CSF-1 will not necessarily increase invasion in an CSF-1R expressing breast epithelial cell lines 
(Gunawardane et al., 2005) . To invade, the cell needs to go through morphological changes 
making invasion and migration possible like ability break down of the surrounding tissue to be 
able to move. Invasive behavior has been connected to cell-surface associated proteolytic 
activity stemming from interaction with urokinase plasminogen activator (uPA) and its surface 
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receptor (Ossowski, 1992; Ossowski, 1988). Expression of CSF-1R has been connected to 
increased secretion of uPA in murine mammary epithelial cell lines and human breast 
carcinomas (Sapi et al., 1996; Kacinski, 1997). CSF-1 stimulation can also stimulate uPA-
mediated invasion in ovarian and carcinomas and induce increased uPA mRNA in murine 
fibroblasts (Chambers et al., 1995; Stacey et al., 1995) Increasing CSF-1R using either 
dexamethasone or CSF-1 results in increased invasiveness in increased uPA production and 
invasion in mammary carcinoma cells (Kacinski, 1997). CSF-1 stimulated  induction of uPA in 
murine fibroblasts was reported to involve activation of E twenty-six (Ets) transcription factors 
and Ras signaling (Stacey et al., 1995). Mutation of Ets-2 can interrupt CSF-1 signaling 
pathways in the breast carcinoma cell line BT20 making CSF-1 unable to cause increased 
invasion. This happens by inhibition of CSF-1 induced c-myc, c-fos and c-jun (Sapi et al., 
1998b). Apart from uPA, other factors are involved in invasive activity of CSF-1R expressing 
cells. Inhibition of collagenases can decrease CSF-1 stimulated invasion (Chambers et al., 
1995). The fact that both the cells expressing CSF-1R and the CSF-1R negative cells could be 
found in the membrane of the Matrigel-coated inserts show that this cell line has some ability 
to invade the Matrigel, this could in part be caused by an increased level of uPA and 
collagenases in the CSF-1R positive cells. An increased ability of the cells to migrate toward 
the chemoattractant could also increase invasion. One invasive cell can break down the Matrigel 
and make path for less invasive cells to migrate and a cell with higher motility would move 
through the pores faster. Some cells were also found in the membrane of the CSF-1R negative 
Matrigel-coated inserts which indicate that this cell line is not completely dependent on CSF-
1R stimulation for invasion. 
 
 
Effect of the Matrigel on the morphology of the cells 
The Matrigel used in this study did according to the manufacturer contain extracellular matrix 
(ECM) proteins (including laminin, collagen type IV, heparine sulfate proteoglycane and 
entactin), growth factors and other components. The levels of growth factors were reduced in 
this Matrigel, excluding TGF-. According to the manufacturer,  Corning Matrigel was 
extracted from the Engelbreth-Holm-Swarm mouse sarcoma. Matrigel might not just represent 
a barrier for the cells to invade, the component of the Matrigel may also have an effect on gene 
expression, growth characteristics and morphology of the cells. Components of the ECM can 
provide critical physical and biochemical cues to epithelial cells (Sisci et al., 2004). Laminin-
111 has previously been shown to affect breast carcinoma cells by making them grow in web-
like cell organizations and reducing Estrogen receptor- at mRNA-levels and laminin-1 can 
also change epithelial cell polarity (Neubauer et al., 2009; Gudjonsson et al., 2002).  Co-
injection fibroblasts and breast-carcinoma cell line (MCF-7) with Matrigel induced increased 
tumor growth. (Noël et al., 1993) Adhesion to Collagen IV and fibronectin can however reduce 
cell invasion in breast carcinoma cell line MCF-7 (Sisci et al., 2004). 
 
 
Differences in the results of immunohistochemistry and flow cytometry 
The level of CSF-1R expression using flow cytometry was very different from the level of CSF-
1R using immunohistochemistry in the CMT-U229 avl 2 cell line. For the 
 20 
immunohistochemical study, a different antibody was used from the flow cytometry. The same 
antibody could not be used because the antibody used in flow cytometry could not stain the 
paraffin embedded samples for immunohistochemistry. This could in part explain the 
differences of the CMT-U229 avl 2 in CSF-1R positive cells observed in 
immunohistochemistry compared to flow cytometry. The antibody used for 
immunohistochemistry could have a greater sensitivity for the receptor. The increased level of 
positive cells could also be a result of the selection which happens while culturing and 
passaging cells. Because of the generally weak staining using the 1:500 dilution this result was 
discounted from the immunohistochemistry. If the experiment was to be repeated an antibody 
dilution of 1:250 would probably be ideal for staining of the CSF-1R receptor in these cell lines.  
 
Another explanation for the different percentages of CSF-1R expression in flow cytometry and 
immunohistochemistry could be the choice of cut-off. The areas gated in the flow cytometry 
histograms were the ones with strongest Phycoerythrin (PE)-signals i.e. PE positive and lowest 
PE-signals i.e. PE-negative respectively (Figure 1 A). To quantitatively decide the continuum 
of positivity by eye is almost impossible in immunohistochemical stainings. Thus, a software 
to measure this should have been beneficial and would most probable have given more similar 
results on the CSF-1R expression. 
 
 
CONCLUSIONS 
The colony stimulating factor-1 receptor is expressed in the CMT-U229 avl 2 cell line and the 
expression is associated with increased migration and invasion in vitro. Several signaling 
pathways involving E-cadherin, uPA and more have previously been shown to be involved in 
the CSF-1R signaling pathway. These signaling pathways could possibly be the cause of 
increased migration and invasion of the CSF-1R  positive cells in the CMT-U229 avl 2 cell line. 
The results indicate that CSF-1R may play a role in the development of metastasis in canine 
mammary cancer. 
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